Literature DB >> 9134172

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.

E Jantunen1, P Ruutu, L Niskanen, L Volin, T Parkkali, P Koukila-Kähkölä, T Ruutu.   

Abstract

In order to analyze the incidence and risk factors for invasive fungal infection (IFI) after allogeneic BMT, 142 consecutive adult BMT recipients (131 sibling donors, 11 unrelated donors) transplanted in 1989-1993 were retrospectively analyzed. There were 21 cases with definite or probable IFI (incidence 15%) (Aspergillus, 15; Candida, four; Fusarium, one; Absidia, one). The median time to the diagnosis of IFI was 136 days after BMT (range 6-466 days). Only 14% of the IFIs were found during the neutropenic period post-BMT. Of the pretransplant characteristics, hematological disease (MDS vs other) (P = 0.001) and unrelated donor (P = 0.01) were risk factors for IFI. Acute GVHD grade III-IV (P = 0.03) and extensive chronic GVHD (P = 0.0002) were also found to be significant risk factors. Only three patients with IFI (14%) became long-term survivors. Invasive fungal infections tended to develop late after BMT, were usually caused by Aspergillus sp., and were strongly associated with GVHD and its treatment. Better prophylaxis and treatment of IFI are needed. More effective prophylaxis for GVHD might decrease the risk of IFI after allogeneic BMT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134172     DOI: 10.1038/sj.bmt.1700737

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  28 in total

Review 1.  Role of itraconazole in haematology/oncology.

Authors:  N A Pandya; A A Atra; U Riley; C R Pinkerton
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

2.  Secondary Antifungal Prophylaxis in Hematopoietic Stem Cell Transplantation (HSCT)/Acute Leukemia Patients.

Authors:  Jean El Cheikh
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 3.  Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.

Authors:  Rami Sherif; Brahm H Segal
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

4.  Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.

Authors:  Stefanie Hennig; Claire E Wainwright; Scott C Bell; Hugh Miller; Lena E Friberg; Bruce G Charles
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 5.  Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Zahida Bhatti; Aasma Shaukat; Nikolaos G Almyroudis; Brahm H Segal
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

6.  Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.

Authors:  Aasma Shaukat; Faris Bakri; Paul Young; Theresa Hahn; Donna Ball; Maria R Baer; Meir Wetzler; James L Slack; Peter Loud; Myron Czuczman; Philip L McCarthy; Thomas J Walsh; Brahm H Segal
Journal:  Mycopathologia       Date:  2005-02       Impact factor: 2.574

7.  Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis.

Authors:  Andrea Francesconi; Miki Kasai; Ruta Petraitiene; Vidmantas Petraitis; Amy M Kelaher; Robert Schaufele; William W Hope; Yvonne R Shea; John Bacher; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

8.  Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands.

Authors:  Jeroen P Jansen; Amy K O'Sullivan; Elly Lugtenburg; Lambert F R Span; Jeroen J W M Janssen; Wiro B Stam
Journal:  Ann Hematol       Date:  2010-04-10       Impact factor: 3.673

9.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

10.  Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Ghislaine M Gallez-Hawkins; Lia Thao; Joycelynne Palmer; Andrew Dagis; Xiuli Li; Anne E Franck; Bernard Tegtmeier; Simon F Lacey; Don J Diamond; Stephen J Forman; John A Zaia
Journal:  Biol Blood Marrow Transplant       Date:  2009-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.